Cargando…

Novel N-substituted aminobenzamide scaffold derivatives targeting the dipeptidyl peptidase-IV enzyme

BACKGROUND: The dipeptidyl peptidase-IV (DPP-IV) enzyme is considered a pivotal target for controlling normal blood sugar levels in the body. Incretins secreted in response to ingestion of meals enhance insulin release to the blood, and DPP-IV inactivates these incretins within a short period and st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Balas, Qosay A, Sowaileh, Munia F, Hassan, Mohammad A, Qandil, Amjad M, Alzoubi, Karem H, Mhaidat, Nizar M, Almaaytah, Ammar M, Khabour, Omar F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896277/ https://www.ncbi.nlm.nih.gov/pubmed/24470754 http://dx.doi.org/10.2147/DDDT.S53522

Ejemplares similares

Virtual Lead Identification of Farnesyltransferase Inhibitors Based on Ligand and Structure-Based Pharmacophore Techniques
por: Al-Balas, Qosay A., et al.
Publicado: (2013)

Generation of the First Structure-Based Pharmacophore Model Containing a Selective “Zinc Binding Group” Feature to Identify Potential Glyoxalase-1 Inhibitors
por: Al-Balas, Qosay, et al.
Publicado: (2012)

Potassium-3-beta-hydroxy-20-oxopregn-5-en-17-alpha-yl sulfate: a novel inhibitor of 78 kDa glucose-regulated protein
por: Mhaidat, Nizar M, et al.
Publicado: (2016)

Hybridization and antibiotic synergism as a tool for reducing the cytotoxicity of antimicrobial peptides
por: Almaaytah, Ammar, et al.
Publicado: (2018)

In vivo antimicrobial activity of the hybrid peptide H4: a follow-up study
por: Almaaytah, Ammar, et al.
Publicado: (2018)

Synthesis, antimicrobial and in vitro antitumor activities of a series of 1,2,3-thiadiazole and 1,2,3-selenadiazole derivatives
por: Mhaidat, Nizar M, et al.
Publicado: (2015)

Novel glyoxalase-I inhibitors possessing a “zinc-binding feature” as potential anticancer agents
por: Al-Balas, Qosay A, et al.
Publicado: (2016)

Multi-Armed 1,2,3-Selenadiazole and 1,2,3-Thiadiazole Benzene Derivatives as Novel Glyoxalase-I Inhibitors
por: Al-Balas, Qosay A., et al.
Publicado: (2019)

Metformin Eased Cognitive Impairment Induced by Chronic L-methionine Administration: Potential Role of Oxidative Stress
por: Alzoubi, Karem. H, et al.
Publicado: (2014)

Tackling dipeptidyl peptidase IV in neurological disorders
por: Al-Badri, Ghaith, et al.
Publicado: (2018)

Dipeptidyl Peptidase IV as a Muscle Myokine
por: Kluess, Heidi A.
Publicado: (2020)

Angioedema associated with dipeptidyl peptidase-IV inhibitors
por: Cassano, Nicoletta, et al.
Publicado: (2021)

A3, a Scorpion Venom Derived Peptide Analogue with Potent Antimicrobial and Potential Antibiofilm Activity against Clinical Isolates of Multi-Drug Resistant Gram Positive Bacteria
por: Almaaytah, Ammar, et al.
Publicado: (2018)

Peptide consensus sequence determination for the enhancement of the antimicrobial activity and selectivity of antimicrobial peptides
por: Almaaytah, Ammar, et al.
Publicado: (2016)

Development of novel ultrashort antimicrobial peptide nanoparticles with potent antimicrobial and antibiofilm activities against multidrug-resistant bacteria
por: Almaaytah, Ammar, et al.
Publicado: (2017)

Awareness of pharmacy researchers about the national research code of ethics: A study from Jordan
por: Alrabadi, Nasr N., et al.
Publicado: (2021)

Synthesis, Antibacterial Evaluation and QSAR of α-Substituted-N(4)-Acetamides of Ciprofloxacin and Norfloxacin
por: Qandil, Amjad M., et al.
Publicado: (2014)

Enhanced Antimicrobial Activity of AamAP1-Lysine, a Novel Synthetic Peptide Analog Derived from the Scorpion Venom Peptide AamAP1
por: Almaaytah, Ammar, et al.
Publicado: (2014)

Downregulation of Signaling-active IGF-1 by Dipeptidyl Peptidase IV (DPP-IV)
por: Lin, Ching-Ting, et al.
Publicado: (2010)

Potential Role of Dipeptidyl Peptidase IV in the Pathophysiology of Heart Failure
por: Salles, Thiago A., et al.
Publicado: (2015)

Dipeptidyl-Peptidase IV Activity Is Correlated with Colorectal Cancer Prognosis
por: Larrinaga, Gorka, et al.
Publicado: (2015)

Peptidases in human bronchoalveolar lining fluid, macrophages, and epithelial cells: Dipeptidyl (amino)peptidase IV, aminopeptidase N, and dipeptidyl (carboxy)peptidase (angiotensin-converting enzyme)()
por: Juillerat-Jeanneret, Lucienne, et al.
Publicado: (1997)

Structural Similarities, in Relation with the Cross-Reactivity, of Hymenoptera Allergenic Dipeptidyl Peptidases IV—An Overall Comparison Including a New Dipeptidyl Peptidase IV Sequence from Vespa velutina
por: Monsalve, Rafael I., et al.
Publicado: (2023)

Nature of action of Sitagliptin, the dipeptidyl peptidase-IV inhibitor in diabetic animals
por: Davis, Joseph A., et al.
Publicado: (2010)

Comprehensive analysis of the Co-structures of dipeptidyl peptidase IV and its inhibitor
por: Nojima, Hiroyuki, et al.
Publicado: (2016)

Constituents of Coreopsis lanceolata Flower and Their Dipeptidyl Peptidase IV Inhibitory Effects
por: Kim, Bo-Ram, et al.
Publicado: (2020)

CD26/Dipeptidyl Peptidase IV and Its Multiple Biological Functions
por: Pan, Kelsey, et al.
Publicado: (2021)

Assessment of serum dipeptidyl peptidase-IV levels in autoimmune thyroid disease
por: Zhang, Yuanyuan, et al.
Publicado: (2022)

Pharmacological and Clinical Studies of Medicinal Plants That Inhibit Dipeptidyl Peptidase-IV
por: Rohani, et al.
Publicado: (2023)

New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors
por: Cui, Chenkai, et al.
Publicado: (2022)

Dipeptidyl Peptidase IV Inhibition Exerts Renoprotective Effects in Rats with Established Heart Failure
por: Arruda-Junior, Daniel F., et al.
Publicado: (2016)

Multi-drug resistance 1 genetic polymorphism and prediction of chemotherapy response in Hodgkin's Lymphoma
por: Mhaidat, Nizar M, et al.
Publicado: (2011)

Methotrexate and Cyclosporine Treatments Modify the Activities of Dipeptidyl Peptidase IV and Prolyl Oligopeptidase in Murine Macrophages
por: Olivo, R. A., et al.
Publicado: (2008)

A Role for Dipeptidyl Peptidase IV in Suppressing the Malignant Phenotype of Melanocytic Cells
por: Wesley, Umadevi V., et al.
Publicado: (1999)

Dipeptidyl Peptidase IV and Incident Diabetes: The Atherosclerosis Risk in Communities (ARIC) study
por: Luft, Vivian C., et al.
Publicado: (2010)

Dipeptidyl peptidase IV inhibitor attenuates kidney injury in rat remnant kidney
por: Joo, Kwon Wook, et al.
Publicado: (2013)

Endogenous dipeptidyl peptidase IV modulates skeletal muscle arteriolar diameter in rats
por: Neidert, Leslie E., et al.
Publicado: (2018)

Discovery of Food-Derived Dipeptidyl Peptidase IV Inhibitory Peptides: A Review
por: Liu, Rui, et al.
Publicado: (2019)

Computational Analysis of Gynura bicolor Bioactive Compounds as Dipeptidyl Peptidase-IV Inhibitor
por: Rozano, Lina, et al.
Publicado: (2017)

Natural phenolic compounds potentiate hypoglycemia via inhibition of Dipeptidyl peptidase IV
por: Huang, Po-Kai, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3rgl7fpipoo5e0d9kt4rbkncn4